All EU Health Technology Assessment Regulation (EU-HTAR) articles
-
ContentsRegulatory Rapporteur March 2026 – Contents
The March issue of Regulatory Rapporteur focuses on biologicals.
-
EditorialThe innovation era: Where biology meets technology
This issue highlights the rapid evolution of the biologicals landscape and shows why early, transparent regulatory dialogue is now critical to translating scientific breakthroughs into global patient access.
-
JournalThe EU’s Health Technology Assessment Regulation: Implementation one year on
This article looks at the impact of EU-HTAR on national HTA bodies, developers and patients so far, and discusses what comes next


















